Accessibility Menu
Brain Scientific logo

Brain Scientific(OTC) BRSF

Market Cap$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-100%
1 Year-100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Brain Scientific last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-10
Brain Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-25
1 month+0%USD 0.002026-06-25
3 month+500%USD 0.002026-05-04
Year to date+500%USD 0.002025-11-26
1 year-99.92%USD 0.752025-02-21
3 year-99.92%USD 0.752023-08-08
5 year-100%USD 31.452021-08-11
Since inception-100%USD 246.502020-03-18

Brain Scientific Financials at a Glance

Market Cap

$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$214.56K

Net Income (TTM)

-$11.48M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

350.31 (High)

Price

$0.00

Volume

6

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.75

Estimated Earnings Date

Aug 14, 2024

BRSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Brain Scientific

Brain Scientific Inc. is a medical technology company based in Sarasota, Florida, specializing in neurology-focused medical devices. Established in 2013, the company aims to innovate solutions for brain health through advanced technology.

Products and Services
  • NeuroCap: A disposable cap with integrated electrodes for EEG systems
  • NeuroEEG: A clinical-grade device for capturing and visualizing brain activity
  • NeuroNet Cloud: A secure database for storing and analyzing brain-related data
Growth Outlook
  • Expansion into new markets is anticipated, enhancing product reach
  • Continued investment in R&D to drive innovation and product development
  • Strategic partnerships may increase distribution and market presence
Financial Highlights
  • Recent quarterly revenue of $5,080 indicates ongoing operational challenges
  • Trailing twelve months (TTM) revenue shows a significant decline compared to previous periods
  • Cash and cash equivalents decreased to $747,714, reflecting liquidity concerns
Brain Scientific Inc. operates in a niche market with a focus on neurology, offering innovative products designed to address common challenges in brain health monitoring. The company's flagship products, NeuroCap and NeuroEEG, are positioned to meet the growing demand for advanced neurological diagnostics. Despite facing financial hurdles, including a recent quarterly revenue of $5,080 and a TTM revenue decline, the company is actively pursuing growth strategies. Investments in research and development, along with potential partnerships, may provide avenues for future expansion. However, the current financial landscape indicates a need for careful monitoring of cash flow and operational efficiency.
AI Generated • Aug 1, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11

CEO

Hassan Kotob, MBA

Website

www.brainscientific.com

Headquarters

Sarasota, FL 34240, US

BRSF Financials

Key Financial Metrics (TTM)

Gross Margin

25.32%

Operating Margin

-4478.11%

Net Income Margin

-5753.00%

Return on Equity

-681.55%

Return on Capital

-133.81%

Return on Assets

-105.11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.24M

Volume

6

Avg. Volume

0.111

Financials (TTM)

Gross Profit

$54.33K

Operating Income

-$7.72M

EBITDA

-$6.59M

Operating Cash Flow

-$5.94M

Capital Expenditure

-$33.29K

Free Cash Flow

-$5.97M

Cash & ST Invst.

$747.71K

Total Debt

$2.86M

Brain Scientific Performance Analysis

Brain Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 265,747N/A
20222022-12-31USD 214,564-19.3%
Brain Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-31-36.5%
Q22022-06-30-75.9%
Q32022-09-30-70.3%
Q42022-12-31-55.6%
Brain Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -25.21N/A
20222022-12-31USD -12.95-48.6%
Brain Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12022-03-31-1916.7%
Q22022-06-3053.2%
Q32022-09-30-97.1%
Q42022-12-315.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$5.08K

-98.0%

Gross Profit

-$6.46K

-108.4%

Gross Margin

-1.27%

N/A

Market Cap

$700.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$63.64

N/A

Employees

11

N/A

Net Income

-$3.95M

+28.5%

EBITDA

-$103.18K

+97.9%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$747.71K

-4.8%

Total Debt

$2.86M

-73.1%

Accounts Receivable

$947.00

-94.4%

Inventory

$149.56K

+2.4%

Long Term Debt

$7.38K

-99.9%

Short Term Debt

$2.86M

+209.0%

Return on Assets

-1.05%

N/A

Return on Invested Capital

-2.22%

N/A

Free Cash Flow

-$1.25M

+59.6%

Operating Cash Flow

-$1.24M

+59.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AOBIAmerican Oriental Bioengineering, Inc.
$0.01+0.00%
HTGMQHTG Molecular Diagnostics, Inc.
$0.00+0.00%
CLVRClever Leaves Holdings Inc.
$0.00+0.00%
MYMXMymetics Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About BRSF

What is the current price of Brain Scientific?

Brain Scientific is trading at $0.00 per share.

What is the 52-week range for Brain Scientific?

Over the past 52 weeks, Brain Scientific has traded between $0.00 and $0.75.

How much debt does Brain Scientific have?

As of the most recent reporting period, Brain Scientific reported total debt of $2.86M.

How much cash does Brain Scientific have on hand?

Brain Scientific reported $747.71K in cash and cash equivalents in its most recent financial results.

What is Brain Scientific’s dividend yield?

Brain Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services